REDA, GIANLUIGI

REDA, GIANLUIGI  

DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)  

Risultati 1 - 20 di 26 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Biological and molecular characterization of a rare case of cutaneous Richter syndrome 1-dic-2017 G. RedaR. CassinS. FabrisG. CiceriB. FattizzoM. SciumèN. OrofinoU. GianelliA. NeriA. Cortelezzi Article (author) -
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia 1-gen-2018 Reda G.Fattizzo B.Cassin R.Pennisi M.Cairoli R.Cortelezzi A. + Article (author) -
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 28-gen-2021 Reda G.Zucchetto A.Cassin R.Neri A. + Article (author) -
Comprehensive Biological and Molecular Characterization of a RARE Case of Cutaneous Richter Syndrome 1-gen-2015 Ramona CassinGianluigi RedaSonia FabrisNicola OrofinoBruno FattizzoUmberto GianelliAntonino NeriAgostino Cortelezzi Article (author) -
Expression of TLRs in B-CLL: Relationship with Disease Activity 1-gen-2011 Gianluigi RedaBruno FattizzoAlberto ZanellaAgostino Cortelezzi + Article (author) -
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients 1-gen-2020 Lionetti, MartaBarbieri, MarziaFavasuli, VanessaTaiana, ElisaFabris, SoniaCiceri, GabriellaColombo, MonicaReda, GianluigiRossi, DavideBaldini, LucaNeri, Antonino + Article (author) -
Guillain Barrè syndrome in a chronic lymphocytic leukaemia (CLL) patient after subcutaneous alemtuzumab (A) therapy 1-gen-2009 R. CastelliG. RedaA. CortelezziN. Bresolin + Article (author) -
Heminsight to assess patient reported outcomes of patients affected by chronic lymphocytic leukemia in daily clinical practice 1-gen-2017 G. RedaB. FattizzoR. CassinV. MattielloE. OlivaA. Cortelezzi + Article (author) -
Hepcidin levels and their determinants in different types of myelodysplastic syndromes 1-ago-2011 L. DucaA. CortelezziG. RedaM. D. Cappellini + Article (author) -
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2) 30-gen-2020 Re, FrancescaTedeschi, AlessandraReda, GianluigiNeri, Antonino + Article (author) -
Hypogammaglobulinemia in Chronic Lymphocytic Leukemia: A Predictor of Outcome? 1-gen-2017 Gianluigi RedaRamona CassinGiorgia LevatiBruno FattizzoVeronica MattielloFrancesco OnidaAgostino Cortelezzi + Article (author) -
Hypogammaglobulinemia is a strong predictor of time to first treatment in chronic lymphocytic leukemia 1-gen-2017 G. RedaR. CassinG. V. LevatiB. FattizzoV. MattielloA. Cortelezzi + Article (author) -
Idelalisib Rapidly Improves Platelets Function in Patients with Chronic Lymphocytic Leukemia (CLL) 1-gen-2016 Gianluigi RedaRamona CassinAndrea ArtoniBruno FattizzoSilvia La MarcaPaolo BucciarelliFlora PeyvandiAgostino Cortelezzi + Article (author) -
Impact of Bone Marrow Fibrosis and Early Response on Outcome after Azacitidine Therapy in 94 Patients with Myelodisplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia 1-gen-2016 Gianluigi RedaMarta RivaRamona CassinBruno FattizzoMartina PennisiAgostino Cortelezzi + Article (author) -
Impact of bone marrow fibrosis in response to azacitidine in 94 patients with myelodisplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia 1-gen-2016 G RedaR CassinB FattizzoR CairoliA Cortelezzi + Article (author) -
Low-dose Alemtuzumab in Refractory/Relapsed Chronic Lymphocytic Leukemia : Genetic Profile and Long-term Outcome from a Single Center Experience 1-gen-2015 M. SciumèD. VincentiG. RedaN. OrofinoR. CassinA. Cortelezzi + Article (author) -
Lymphocytic infiltrate and p53 protein expression as predictive markers of response and outcome in myelodysplastic syndromes treated with azacitidine 1-nov-2021 Pescia C.Croci G. A.Cassin R.Barella M.Pettine L.Reda G.Sabattini E.Gianelli U. + Article (author) -
New SMAC-Mimetic Compounds Strongly Induce In Vitro Apoptosis of Human Lymphocytes From Patients with Chronic Lymphocytic Leukemia 1-gen-2010 Onida, FrancescoSaporiti, GiorgiaSeneci, PierfaustoReda, GianluigiCortelezzi, AgostinoDeliliers, Giorgio Lambertenghi + Article (author) -
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment 1-nov-2018 Reda, GianluigiCortelezzi, AgostinoNeri, Antonino + Article (author) -
Reduced expression of toll-like receptor 4 in B-chronic lymphocytic leukemia patients with autoimmune complications 1-gen-2013 B FattizzoS LonatiG RedaA Cortelezzi + Article (author) -